Efficacy of Two HMOs in Chinese Infants

NARecruitingINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

July 29, 2024

Primary Completion Date

November 30, 2026

Study Completion Date

June 30, 2027

Conditions
Healthy Infants
Interventions
OTHER

Experimental Group (EG)

Starter infant formula will be administered to the participants orally, ad libtium to 6 months, after which they will transfer to a classical follow-up formula (non-trial formula) until the end of the trial (12 months of age).

OTHER

Control Group (CG)

Starter infant formula will be administered to the participants orally, ad libtium to 6 months, after which they will transfer to a classical follow-up formula (non-trial formula) until the end of the trial (12 months of age).

Trial Locations (1)

Unknown

RECRUITING

The International Peace Maternity & Child Health Hospital of China Welfare Institute, Shanghai

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY